1.
Nandi S, Bagchi MC. Exploring CDKs, Ras-ERK, and PI3K-Akt in Abnormal Signaling and Cancer. J. Can. Res. Updates [Internet]. 2022 Oct. 27 [cited 2024 Apr. 20];11:63-9. Available from: https://neoplasiaresearch.com/pms/index.php/jcru/article/view/691